Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Daniel L Miller, MD, Charles M Rowland, MS, Claude Deschamps, MD, Mark S Allen,

Slides:

Advertisements

Similar presentations

Surgical treatment of hepatic and pulmonary metastases from colon cancer James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Advertisements

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Thomas J. Birdas, MD, Richard P. M

Primary non-Hodgkin’s lymphoma of the lung

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

Cytologically malignant margins of wedge resected stage I non-small cell lung cancer Noriyoshi Sawabata, MD, Akihide Matsumura, MD, Mitsunori Ohota, MD,

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis? Noriyoshi.

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Joshua E. Rosen, BASc, Hari B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy James R Headrick, MD, Francis C Nichols, MD, Daniel L Miller,

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma Sina Ercan, MD, Francis C Nichols,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Surgical treatment of hepatic and pulmonary metastases from colon cancer James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Surgical Treatment of Metachronous Second Primary Lung Cancer

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy Morihito Okada, MD, Hiroyuki Yamagishi,

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Surgical Resection of Rare Esophageal Cancers

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Karen M. Harrison–Phipps, MD, Francis C. Nichols, MD, Cathy D

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Long-term results after pulmonary resection of renal cell carcinoma metastases Stefan Piltz, MD, Georgios Meimarakis, MD, Matthias W Wichmann, MD, Rudolf.

Lorenzo Spaggiari, MD, PhD, Ugo Pastorino, MD

Lobar torsion after pulmonary resection: Presentation and outcome

Bronchobiliary fistula: principles of management

Leiomyosarcoma of the esophagus: results of surgical treatment

Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy Shizuka Kaseda, MD, Teruhiro Aoki, MD, Nanae Hangai,

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Postpneumonectomy Empyema: Results After the Clagett Procedure

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Video-Assisted Thoracoscopic Surgery is More Favorable Than Thoracotomy for Resection of Clinical Stage I Non-Small Cell Lung Cancer Bryan A. Whitson,

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies Hon-Chi Suen, MBBS, Bryan F Meyers, MD, Tracey Guthrie, BSN, Mary.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Lewis Y antigen expression and postoperative survival in non–small cell lung cancer Fumihiro Tanaka, MD, Ryo Miyahara, MD, Yohsuke Ohtake, MD, Kazuhiro.

Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Henri Porte, MD, PhD, Joëlle Siat, MD, Benoit Guibert, MD, Francoise.

MTP19-01: T4 N0/N1 nonsmall cell lung cancer can be cured as a first line treatment with an expected five year survival rate as high as 43% provided a.

Surgical management of sternoclavicular joint infections

Role of surgical resection in broncholithiasis

Is there a role for pneumonectomy in pulmonary metastases?1

Thoracic Surgery Survey on Lung Cancer Management

Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Kemp H Kernstine, MD, PhD, Kelley A McLaughlin,

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study Noriyoshi Sawabata, MD, Mitsunori.

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

Neal S Goldstein, MD The Annals of Thoracic Surgery

Effectiveness of Postoperative Irradiation in Stage IIIA Non–Small Cell Lung Cancer According to Regression Tree Analyses of Recurrence Risks Timothy.

Who should decide margin length in pulmonary excision of lung cancer?

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Zenker’s diverticulum in the elderly: is operation justified?

Surgery for pulmonary metastases from colorectal carcinoma

Presentation transcript:

Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Daniel L Miller, MD, Charles M Rowland, MS, Claude Deschamps, MD, Mark S Allen, MD, Victor F Trastek, MD, Peter C Pairolero, MD The Annals of Thoracic Surgery Volume 73, Issue 5, Pages 1545-1551 (May 2002) DOI: 10.1016/S0003-4975(02)03525-7

Fig 1 Probability of survival (death from any cause and death from lung cancer) in 100 patients who underwent resection of a non–small cell lung cancer 1 cm or less in diameter; 34 patients alive at 5 years. Zero time on the abscissa represents the date of thoracotomy. The Annals of Thoracic Surgery 2002 73, 1545-1551DOI: (10.1016/S0003-4975(02)03525-7)

Fig 2 Probability of survival (death from any cause) in 75 patients who underwent formal resection as compared with the 25 patients who underwent limited resection; 31 and 3 patients alive at 5 years for the formal resection and the limited resection groups, respectively (p = 0.03). Zero time on the abscissa represents the date of thoracotomy. The Annals of Thoracic Surgery 2002 73, 1545-1551DOI: (10.1016/S0003-4975(02)03525-7)

Fig 3 Probability of survival (death from any cause) in 75 patients who underwent lobectomy compared with 12 patients who had segmentectomy and 13 patients who had wedge excision of a non–small cell lung cancer 1 cm or less in diameter; 31, 1, and 2 patients alive at 5 years for patients undergoing lobectomy, segmentectomy, and wedge resection, respectively (p = 0.03). Zero time on the abscissa represents the date of thoracotomy. The Annals of Thoracic Surgery 2002 73, 1545-1551DOI: (10.1016/S0003-4975(02)03525-7)

Fig 4 Probability of survival (death from lung cancer) in 75 patients who underwent lobectomy compared with 12 patients who had segmentectomy and 13 patients who had wedge excision of a non–small cell lung cancer 1 cm or less in diameter; 31, 1, and 2 patients alive at 5 years for patients undergoing lobectomy, segmentectomy, and wedge resection, respectively (p = 0.04). Zero time on the abscissa represents the date of thoracotomy. The Annals of Thoracic Surgery 2002 73, 1545-1551DOI: (10.1016/S0003-4975(02)03525-7)

Fig 5 Probability of survival (death from any cause) in 93 patients without lymph node metastases as compared with the 7 patients who had lymph node metastases; 31 and 3 patients alive at 5 years for patients with negative and positive lymph nodes, respectively (p = 0.15). Zero time on the abscissa represents the date of thoracotomy. The Annals of Thoracic Surgery 2002 73, 1545-1551DOI: (10.1016/S0003-4975(02)03525-7)

Fig 6 Probability of survival (death from lung cancer) in 93 patients without lymph node metastases as compared with the 7 patients who had lymph node metastases; 31 and 3 patients alive at 5 years for patients with negative and positive lymph nodes, respectively (p = 0.08). Zero time on the abscissa represents the date of thoracotomy. The Annals of Thoracic Surgery 2002 73, 1545-1551DOI: (10.1016/S0003-4975(02)03525-7)